SRCL LIMITED

Financial Health Score: B+ (Stable Structural Health, Dependent on Parent)

This grade reflects a business with robust corporate genetics and excellent administrative health, but one where the standalone financial vitals are obscured by its status as a subsidiary. The company benefits from the "corporate immunity" of a large parent, which shields it from many typical market illnesses, but its low share capital and lack of visible standalone liquidity metrics require a note of caution.

1. Key Vital Signs

• Corporate Lineage & Ownership (The "Genetic" Profile): The company is majority-owned (over 75% of shares and voting rights) by Stericycle International Ltd. This is the most critical vital sign. It indicates that SRCL LIMITED operates within the circulatory system of a much larger, global corporate entity. If the subsidiary experiences financial distress, the parent company has both the legal control and the likely financial capacity to provide life support (capital injections).
• Corporate Longevity (The "Biological Age"): Incorporated in 1996, the company is nearly 28 years old. This advanced age indicates a robust constitution; the business has survived multiple economic cycles, regulatory changes, and industry shifts.
• Regulatory Compliance (The "Immune System"): The company's accounts and confirmation statements are fully up to date, with the next accounts not due until September 2026. This demonstrates strong administrative health and a healthy "immune system" against regulatory penalties or strike-off actions by Companies House.
• Share Capital (The "Bone Marrow"): The issued share capital stands at a mere £67. While this might look like a symptom of anemia (severely undercapitalized), in subsidiaries, this is often a structural anomaly. It typically means the company relies on intercompany loans from its parent (Stericycle) rather than share capital to fund its operations and working capital.

2. Symptoms Analysis

• Historical Pivots: The company has changed its name four times (from Clinical Waste Resources to Medipower, to South West Energy, to Sterile Technologies, and finally to SRCL). These name changes are not necessarily symptoms of an identity crisis, but rather a series of "treatments" or strategic pivots—likely aligning the brand with acquisitions or shifting service lines until it settled on its current alignment with the Stericycle brand.
• Missing Financial Vitals: The current data set lacks the pulse (cash flow) and blood pressure (liquidity ratios) metrics—such as current assets, current liabilities, and net assets. Because of this, we cannot measure the company's standalone financial fitness. However, the fact that it files "Full" accounts (typically required for medium/large companies) suggests it meets the size thresholds that require a more detailed public examination, indicating it is not a micro-enterprise.

3. Diagnosis

Diagnosis: Stable, Subsidiary-Dependent Constitution

SRCL LIMITED is a mature, active entity operating in the specialized medical waste disposal sector. The primary diagnosis is that of a healthy subsidiary whose financial wellness is intrinsically tied to its parent, Stericycle International Ltd.

The minimal share capital (£67) is a common structural feature in corporate groups where the parent company prefers to finance the subsidiary through debt rather than equity. While this means the company would be technically insolvent if the parent withdrew its support, this is a low-risk scenario given Stericycle's global dominance in medical waste compliance. The company shows no symptoms of administrative distress; its filing record is immaculate, and its corporate governance appears well-maintained under the direction of its current director and parent PSC.

4. Prognosis & Recommendations

Prognosis: The future outlook is highly stable, contingent on the continued health of the parent company. As long as Stericycle International Ltd remains financially sound and supportive, SRCL LIMITED will continue to operate with a strong safety net.

Recommendations for Financial Wellness: 1. Monitor Intercompany Health: While the parent provides a safety net, local management should ensure that intercompany balances (loans from the parent) are properly documented and reviewed. Over-reliance on parent debt can sometimes lead to sudden withdrawal symptoms if the parent's global strategy changes. 2. Maintain Administrative Hygiene: The company has excellent compliance habits. Continue this preventative care to avoid unnecessary regulatory friction. 3. Review Working Capital: Ensure that the low share capital is supported by adequate working capital facilities (either internally generated or via the parent) so that the company can meet its short-term debts as they fall due without constant emergency transfusions from the parent.